Urowitz MB et al. The bimodal mortality pattern of systemic lupus erythematosus . Am J Med1976; 69: 221-225.
2.
Libby P., Hansson GKInvolvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest1991; 64: 5-15.
3.
Vaarala O. et al. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet1993; 341: 923-925.
4.
Hörkkö S. et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. J Clin Invest1996 ; 98: 815-825.
5.
Hasunuma Y. et al. Involvement of β2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol1997; 107: 569-573.
6.
Aho K. et al. Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus. Clin Exp Rheumatol1996 ; 14: 499-506.
7.
Salonen JT et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet1992; 339: 883-887.
8.
Puurunen M. et al. Antibodies to oxidised low-density lipoprotein predicting myocardial infarction. Arch Int Med1994; 154: 2605-2609.
9.
Witztum JLThe oxidation hypothesis of atherosclerosis. Lancet1994; 344: 793-795.
10.
Amengual O. et al. Antibodies against oxidized low-density lipoprotein (ox-LDL) in 107 patients with antiphospholipid syndrome (APS) . Lupus1996; 5: 537.
11.
Cabiedes J. , Cabral AR, Alarcón-Segovia. Clinical manifestations of antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol1995; 22: 1899-1906.
12.
Puurunen M. et al. Antibodies to phospholipid-binding proteins and occurrence of clinical manifestations in patients with systemic lupus erythematosus. Clin Immuno Immunopath1996 ; 80: 16-22.
13.
Vaarala O. et al. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemotasis1996 ; 75: 456-459.
14.
Roubey RAAutoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood1994; 84: 2854-2867.
15.
Libby P.Molecular bases of the acute coronary syndromes. Circulation1995; 91: 2844-2850.
16.
Yamazaki M. et al. Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost1994; 71: 424-427.
17.
Petri M.Thrombosis and systemic lupus erythematosus: The Hopkins Lupus Cohort perspective . Scand J Rheumatol1995; 25: 191-193.
